113 related articles for article (PubMed ID: 30336533)
1. MiR-33 may be a Biological Marker for Coronary Heart Disease.
Xie Z; Ma P
Clin Lab; 2018 Oct; 64(10):1755-1760. PubMed ID: 30336533
[TBL] [Abstract][Full Text] [Related]
2. Altered Plasma miR-144 as a Novel Biomarker for Coronary Artery Disease.
Chen B; Luo L; Wei X; Gong D; Jin L
Ann Clin Lab Sci; 2018 Jul; 48(4):440-445. PubMed ID: 30143484
[TBL] [Abstract][Full Text] [Related]
3. Expression of miR-126 and its potential function in coronary artery disease.
Wang X; Lian Y; Wen X; Guo J; Wang Z; Jiang S; Hu Y
Afr Health Sci; 2017 Jun; 17(2):474-480. PubMed ID: 29062343
[TBL] [Abstract][Full Text] [Related]
4. Circulating miR-106a may Function as Potential Biomarkers in Patients with Coronary Artery Disease.
Ding H; Hu CX; Xu JK
Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625362
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease.
Li H; Gao F; Wang X; Wu J; Lu K; Liu M; Li R; Ding L; Wang R
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064817
[No Abstract] [Full Text] [Related]
6. Plasma miR-208b and miR-499: Potential Biomarkers for Severity of Coronary Artery Disease.
Wang W; Li T; Gao L; Li Y; Sun Y; Yao HC
Dis Markers; 2019; 2019():9842427. PubMed ID: 31885748
[TBL] [Abstract][Full Text] [Related]
7. [Association between plasma levels of microRNA-126 and coronary collaterals in patients with coronary artery disease].
Nie X; Su L; Zhou Y; Zhao Y; Shi D; Liu Y; Zhou Z; Zhou Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jul; 42(7):561-5. PubMed ID: 25327597
[TBL] [Abstract][Full Text] [Related]
8. Plasma MicroRNA-126-5p is Associated with the Complexity and Severity of Coronary Artery Disease in Patients with Stable Angina Pectoris.
Li HY; Zhao X; Liu YZ; Meng Z; Wang D; Yang F; Shi QW
Cell Physiol Biochem; 2016; 39(3):837-46. PubMed ID: 27497911
[TBL] [Abstract][Full Text] [Related]
9. The relationship of plasma miR-503 and coronary collateral circulation in patients with coronary artery disease.
Fei Y; Hou J; Xuan W; Zhang C; Meng X
Life Sci; 2018 Aug; 207():145-151. PubMed ID: 29870767
[TBL] [Abstract][Full Text] [Related]
10. Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease.
Wang X; Chen LL; Zhang Q
Cardiovasc Ther; 2016 Jun; 34(3):138-43. PubMed ID: 26996787
[TBL] [Abstract][Full Text] [Related]
11. High serum YKL-40 level positively correlates with coronary artery disease.
Jin Y; Cao JN; Wang CX; Feng QT; Ye XH; Xu X; Yang CJ
Biomark Med; 2017 Feb; 11(2):133-139. PubMed ID: 28097894
[TBL] [Abstract][Full Text] [Related]
12. Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease.
Dong J; Liang YZ; Zhang J; Wu LJ; Wang S; Hua Q; Yan YX
J Atheroscler Thromb; 2017 Apr; 24(4):430-441. PubMed ID: 27629254
[TBL] [Abstract][Full Text] [Related]
13. Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease.
Kumar D; Narang R; Sreenivas V; Rastogi V; Bhatia J; Saluja D; Srivastava K
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32033332
[TBL] [Abstract][Full Text] [Related]
14. Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease.
Amr KS; Abdelmawgoud H; Ali ZY; Shehata S; Raslan HM
Br J Biomed Sci; 2018 Apr; 75(2):82-87. PubMed ID: 29452547
[TBL] [Abstract][Full Text] [Related]
15. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.
Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF
Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-765 and miR-149: potential noninvasive diagnostic biomarkers for geriatric coronary artery disease patients.
Ali Sheikh MS; Xia K; Li F; Deng X; Salma U; Deng H; Wei Wei L; Yang TL; Peng J
Biomed Res Int; 2015; 2015():740301. PubMed ID: 25664324
[TBL] [Abstract][Full Text] [Related]
17. [Neoangiogenesis and coronary atherosclerosis: diagnostic value of a novel biochemical marker placenta growth factor in patients with ischemic heart disease].
Shevchenko AO; Shevchenko OP; Orlova OV; Tulikov MV
Kardiologiia; 2006; 46(11):9-15. PubMed ID: 17159877
[TBL] [Abstract][Full Text] [Related]
18. MiR-15a Functions as a Diagnostic Biomarker for Coronary Artery Disease.
Pan X; He Y; Ling S; Chen Z; Yan G
Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776741
[TBL] [Abstract][Full Text] [Related]
19. Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.
Satoh M; Takahashi Y; Tabuchi T; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
Clin Sci (Lond); 2015 Apr; 128(8):483-91. PubMed ID: 25385173
[TBL] [Abstract][Full Text] [Related]
20. Association between elevated plasma microRNA-223 content and severity of coronary heart disease.
Guo JF; Zhang Y; Zheng QX; Zhang Y; Zhou HH; Cui LM
Scand J Clin Lab Invest; 2018 Sep; 78(5):373-378. PubMed ID: 29888618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
